Free Trial Information
BioCentury | Jul 8, 2017
Finance

A clinical quarter

...Inc. (NYSE:PFE) Fremanezumab Chronic and episodic migraines Submit BLA 2H17 The Female Health Co. (NASDAQ:FHCO) Tamsulosin DRS...
Read More
BioCentury | Dec 31, 2016
Finance

Delivering takeouts

...S.A. Ublituximab Relapsed or refractory CLL Ph III data 1H17 The Female Health Co. (NASDAQ:FHCO) Tamsulosin DRS...
Read More
Items per page:
1 - 2 of 2